Prognostic markers in AML: focus on CBFL
Leukemia Supplements · 2012
DOI: 10.1038/leusup.2012.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia Supplements, 2012. Verfasst von R Cairoli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hematology Section, Valduce Hospital, Como, Italy; Division of Haematology, Niguarda Hospital, Milan, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hematology Section, Valduce Hospital, Como, Italy; Division of Haematology, Niguarda Hospital, Milan, Italy.
- Department of Biology and Genetics for Medical Sciences, University of Milan , Milan, Italy.
- Division of Haematology, Niguarda Hospital , Milan, Italy.
Zitieren
APA
Cairoli, R., Beghini, A., Turrini, M., Bertani, G., & Morra, E. (2012). Prognostic markers in AML: focus on CBFL. Leukemia Supplements. https://doi.org/10.1038/leusup.2012.9
Vancouver
Cairoli R, Beghini A, Turrini M, Bertani G, Morra E. Prognostic markers in AML: focus on CBFL. Leukemia Supplements. 2012. doi:10.1038/leusup.2012.9
BibTeX
@article{Cairoli2012,
author = {Cairoli, R and Beghini, A and Turrini, M and Bertani, G and Morra, E},
title = {Prognostic markers in AML: focus on CBFL},
journal = {Leukemia Supplements},
year = {2012},
doi = {10.1038/leusup.2012.9}
}
EUVIMED